Daewon Pharmaceutical Co. Ltd. - Asset Resilience Ratio

Latest as of June 2026: 7.41%

Daewon Pharmaceutical Co. Ltd. (003220) has an Asset Resilience Ratio of 7.41% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 003220 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩42.46 Billion

≈ $28.77 Million USD Cash + Short-term Investments

Total Assets

₩573.33 Billion

≈ $388.54 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2025)

This chart shows how Daewon Pharmaceutical Co. Ltd.'s Asset Resilience Ratio has changed over time. See cash generation quality of Daewon Pharmaceutical Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Daewon Pharmaceutical Co. Ltd.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Daewon Pharmaceutical Co. Ltd. balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩42.46 Billion	7.41%
Total Liquid Assets	₩42.46 Billion	7.41%

Asset Resilience Insights

Limited Liquidity: Daewon Pharmaceutical Co. Ltd. maintains only 7.41% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Daewon Pharmaceutical Co. Ltd. Industry Peers by Asset Resilience Ratio

Compare Daewon Pharmaceutical Co. Ltd.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Shan Dong Dong-E E-Jiao Co Ltd SHE:000423	Drug Manufacturers - Specialty & Generic	20.44%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	Drug Manufacturers - Specialty & Generic	2.09%
Henan Taloph Pharmaceutical Stock Co Ltd SHG:600222	Drug Manufacturers - Specialty & Generic	2.75%
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	Drug Manufacturers - Specialty & Generic	2.98%

Annual Asset Resilience Ratio for Daewon Pharmaceutical Co. Ltd. (2011–2025)

The table below shows the annual Asset Resilience Ratio data for Daewon Pharmaceutical Co. Ltd..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	4.77%	₩29.28 Billion ≈ $19.84 Million	₩613.65 Billion ≈ $415.86 Million	-0.21pp
2024-12-31	4.98%	₩29.05 Billion ≈ $19.69 Million	₩583.39 Billion ≈ $395.35 Million	+4.97pp
2023-12-31	0.01%	₩47.71 Million ≈ $32.33K	₩508.00 Billion ≈ $344.26 Million	-4.41pp
2022-12-31	4.42%	₩20.04 Billion ≈ $13.58 Million	₩453.55 Billion ≈ $307.36 Million	+1.36pp
2021-12-31	3.05%	₩13.12 Billion ≈ $8.89 Million	₩429.58 Billion ≈ $291.12 Million	+3.03pp
2020-12-31	0.02%	₩81.50 Million ≈ $55.23K	₩335.21 Billion ≈ $227.17 Million	-1.88pp
2019-12-31	1.91%	₩6.25 Billion ≈ $4.23 Million	₩327.53 Billion ≈ $221.96 Million	+1.22pp
2018-12-31	0.69%	₩1.89 Billion ≈ $1.28 Million	₩275.44 Billion ≈ $186.66 Million	-1.72pp
2017-12-31	2.41%	₩5.47 Billion ≈ $3.71 Million	₩227.20 Billion ≈ $153.97 Million	+0.02pp
2016-12-31	2.39%	₩5.13 Billion ≈ $3.48 Million	₩214.68 Billion ≈ $145.49 Million	-0.39pp
2015-12-31	2.78%	₩5.41 Billion ≈ $3.67 Million	₩194.75 Billion ≈ $131.98 Million	-0.87pp
2014-12-31	3.65%	₩6.59 Billion ≈ $4.47 Million	₩180.62 Billion ≈ $122.40 Million	-1.27pp
2013-12-31	4.92%	₩7.87 Billion ≈ $5.34 Million	₩160.14 Billion ≈ $108.52 Million	+4.58pp
2012-12-31	0.34%	₩499.06 Million ≈ $338.20K	₩147.13 Billion ≈ $99.70 Million	-0.09pp
2011-12-31	0.43%	₩597.00 Million ≈ $404.58K	₩140.39 Billion ≈ $95.14 Million	--

pp = percentage points

About Daewon Pharmaceutical Co. Ltd.

KO:003220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$118.96 Million

₩175.54 Billion KRW

Market Cap Rank

#18564 Global

#877 in Korea

Share Price

₩8190.00

Change (1 day)

-0.73%

52-Week Range

₩7240.00 - ₩13450.00

All Time High

₩23535.34